Potential of next-generation sequencing in the NHS for patients with MPNs - 101793

Spotlight
Video

Potential of next-generation sequencing in the NHS for patients with MPNs

VJHemOnc has 1435 videos Subscribe Here

Loading........
Description: Myeloproliferative Neoplasms (MPNs) carry a risk of complications, such as thrombosis; the degree of risk is influenced in part by genetic factors. In this interview, recorded at the Myeloproliferative Neoplasms Advances Day 2017 in London, UK, Angela Hamblin, MD, PhD, of Oxford Molecular Diagnostics Centre, Oxford UK, discusses how her team uses next-generation sequencing to identify known mutations in a patient sample, and the exciting applications that this may have in the future, including personalized treatment and minimal residual disease monitoring.
Shared By : VJHemOnc
Posted on : 12/05/17
Added : 9 months ago